Illumina announced yesterday that it has acquired Advanced Liquid Logic (ALL), the leading company offering Digital Microfluidics Solutions. Advanced Liquid Logic was founded in 2004 by Dr. Michael Pollack and Dr. Vamsee Pamula and based at Morrisville, North Carolina. Advanced Liquid Logic is a result of technology developed during Vamsee’s PhD and Michael’s postdoctoral research at Richar Fair’s lab in Duke University’s Pratt School of Engineering.
Since 2004, Advanced Liquid Logic has launched multiple products, including Mondrian SP Workstation from NuGEN technologies that uses disposable microfluidic cartridges to automate sample preparation for next-generation DNA sequencing. Advanced Liquid Logic also collaborates with physicians at Duke’s Jean and George Brumley Jr. Neonatal Perinatal Research Institute (NPRI) to screen lysosomal storage disorders (LSDs) in new born babies.
Illumina said the acquisition of will help Illumina offer simple solution to its goal of providing customers with tools to go from biological sample to answer quickly in Next-generation sequencing workflow. Such a simple procedure will not only make NGS work flow easy, but also minimize the risk of errors and reduce hands-on time in the lab.
Christian Henry, Senior Vice President and General Manager of Illumina’s Genomic Solutions business, said
For our research customers, ALL’s technology will further streamline the industry’s simplest NGS workflow, while for clinical and applied markets, where ease of use and consistency are especially valued, it will allow us to offer integrated, end-to-end solutions. ALL brings an impressive IP portfolio in digital microfluidics and a talented team with a track record of innovation.